Skip to content

Investigating the neural basis of interoceptive sensation and behavioral change using transcutaneous auricular vagus nerve stimulation (taVNS)

Investigating the neural basis of interoceptive sensation and behavioral change using transcutaneous auricular vagus nerve stimulation (taVNS) - Investigating the neural basis of interoceptive sensation and behavioral change using transcutaneous auricular vagus nerve stimulation (taVNS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059757
Enrollment
200
Registered
2025-11-13
Start date
2025-11-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

Cognitive behavioral Training of Interoception: The interoception training task (approx. 30 minutes) using a PC program will be administered once daily for 5 consecutive days. taVNS stimulation: 30

Sponsors

National Center for Neurology and Psychiatry, National Institute of Mental Health
Lead Sponsor
Tamagawa University Brain Science Institute Tokyo Kasei Gakuin University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Individuals aged 18 to 59 years at the time of informed consent. 2) Healthy adults with no regular hospital visits or medication use.

Exclusion criteria

Exclusion criteria: Behavioral Experiments Individuals with a cochlear implant, cardiac pacemaker, or implanted Vagus Nerve Stimulator (VNS). Individuals with an injury to the auricular area (ear). Individuals who have undergone a cerebrospinal fluid (CSF) shunt procedure. Individuals with a diagnosis of glaucoma. Smokers. Individuals with frequent cardiac arrhythmias. Individuals whose resting heart rate is consistently below 60 beats per minute (bpm). MRI Experiments Individuals with a cochlear implant, cardiac pacemaker, or implanted VNS. Individuals for whom MRI scanning poses a certain risk (e.g., tattoos, permanent make-up/cosmetic tattoos, claustrophobia, or other metallic implants/devices). Individuals with an injury to the auricular area (ear). Individuals who have undergone a cerebrospinal fluid (CSF) shunt procedure. Individuals with a diagnosis of glaucoma. Smokers. Individuals with frequent cardiac arrhythmias. Individuals whose resting heart rate is consistently below 60 beats per minute (bpm).

Design outcomes

Primary

MeasureTime frame
The following assessments will be performed before and after the 5-day intervention: Altruistic behavior measures Change in brain MRI images

Secondary

MeasureTime frame
State Trait Anxiety Inventory Japanese version and Social Anxiety Disorder Scale Japanese version The Center for Epidemiologic Studies Depression Scale Japanese version Rate of change in Heart Rate Heartbeat Counting Task Metacognition Task Executive Function Measurement Social Value Orientation Multidimensional Assessment of Interoceptive Awareness Japanese version Japanese version of the Patient Health Questionnaire 15 Wellbeing scales Positive Affect Negative Affect Scale Japanese version Psychological Wellbeing Japanese version Cantrils ladder Satisfaction with Life Scale

Countries

Japan

Contacts

Public ContactRuri Katsunuma

National Center for Neurology and Psychiatry, National Institute of Mental Health Department of Behavioral Medicine

katsunuma@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026